Catalent Inc (CTLT)

133.47 +2.58  +1.97% NYSE Oct 26, 16:00 133.47 0.00  0.00% After-Hours: 18:02 USD
View Full Chart
Price Chart
View All CTLT News

News

View All Events

Events

Date Type Description
11/02/2021 Earnings Results Q1 2022 Earnings Results
11/02/2021 08:15 EST Earnings Calls Q1 2022 Earnings Call
08/30/2021 Earnings Results Q4 2021 Earnings Results
08/30/2021 08:15 EST Earnings Calls Q4 2021 Earnings Call
05/04/2021 Earnings Results Q3 2021 Earnings Results
05/04/2021 08:15 EST Earnings Calls Q3 2021 Earnings Call
02/02/2021 Earnings Results Q2 2021 Earnings Results
02/02/2021 08:15 EST Earnings Calls Q2 2021 Earnings Call
11/03/2020 Earnings Results Q1 2021 Earnings Results
11/03/2020 08:15 EST Earnings Calls Q1 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. It operates in four operating segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services.
  • URL: https://www.catalent.com
  • Investor Relations URL: https://investor.catalent.com
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 02, 2021
  • Last Earnings Release: Aug. 30, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 5.38%
IHE iShares US Pharmaceuticals ETF 4.34%
PPH VanEck Pharmaceutical ETF 4.26%
APDMX Artisan Mid Cap Advisor 2.70%
PMEGX T. Rowe Price Instl Mid-Cap Equity Gr 2.57%
RRMGX T. Rowe Price Mid-Cap Growth R 2.56%
PTH Invesco DWA Healthcare Momentum ETF 2.34%
JGMCX Janus Henderson Triton C 2.14%
FXH First Trust Health Care AlphaDEX® ETF 1.94%
BMRRX BlackRock Mid-Cap Growth Equity R 1.89%
FGSRX Franklin Growth R 1.62%
BBMC JPMorgan BetaBuilders US Mid Cap Eq ETF 0.60%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.